ProShares Ultra Profile

USD 0.34  0.63%

ProShares Ultra Summary

ProShares Ultra Nasdaq Biotechnology [BIB] is traded in USA and was established on May 23, 2018. The fund is classified under Sector category within ProShares family. ProShares Ultra Nasdaq Biotechnology currently have 368.9 M in assets under management (AUM). , while the total return for the last 3 years was -9.65%.
Check ProShares Ultra Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Target Price Odds Analysis

Odds Below 54.14HorizonTargetOdds Above 54.14
80.99%30 days 54.14 18.80%
Based on normal probability distribution, the odds of ProShares Ultra to move above current price in 30 days from now is about 18.8% (This ProShares Ultra Nasdaq Biotechnology probability density function shows the probability of ProShares Ultra Etf to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Ardsley Advisory PartnersCall Options750 K27.2 M
Opus Point Partners Management LlcFund Units187.6 K10.3 M
Jane Street Group LlcPut Options167.7 K9.2 M
View ProShares Ultra Diagnostics

ProShares Ultra Nasdaq Risk Profiles

ProShares Ultra Nasdaq Technical Analysis

The output start index for this execution was zero with a total number of output elements of seventeen. ProShares Ultra Nasdaq Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe ProShares Ultra price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

ProShares Ultra Against Markets

Current Ratings

ProShares Ultra 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for ProShares Ultra Nasdaq Biotechnology are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks daily investment results that correspond to two times the daily performance of the Nasdaq Biotechnology Index. ProShares Ultra is traded on NASDAQ General Markets in USA. more
NameProShares Ultra Nasdaq Biotechnology
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerProShares
ExchangeNASDAQ General Markets
Etf FamilyProShares
Fund CategorySector
Portfolio ConcentrationHealth Care
Contact Number866 776 5125
CurrencyUSD - US Dollar
DescriptionProShares Ultra Nasdaq Biotechnology
Inception Date2010-04-07
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management368.9 Million
Average Trading Valume141,425
Asset TypeEquity
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Portfolio ManagerMichael Neches, Tarak Dave
Transfer AgentJPMorgan Chase Bank, N.A.
Fiscal Year EndMay 31
ExchangeThe NASDAQ Stock Market LLC
Market MakerVirtu Financial
Total Expense1.04
Management Fee0.75

Diversify with ProShares Ultra Nasdaq Biotechnology

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add ProShares Ultra Nasdaq Biotechnology to your portfolio
Check also Trending Equities. Please also try CEO Directory module to screen ceos from public companies around the world.